NCT00408460View on ClinicalTrials.gov

Imatinib Mesylate and Paclitaxel in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

August 31, 2010

Study Completion Date

October 31, 2012

Conditions
Malignant Pleural EffusionRecurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
Interventions
DRUG

imatinib mesylate

Given PO

DRUG

paclitaxel

Given IV

Trial Locations (2)

87106

University of New Mexico Cancer Center, Albuquerque

98109

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Washington

OTHER

NCT00408460 - Imatinib Mesylate and Paclitaxel in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter